CSI Market
Sign In | Register

Silexion Therapeutics (SLXN) Annual Balance Sheets

Annual · GAAP · USD millions
Access SLXN quarterly Balance Sheets →
A period-by-period view of the balance sheet from Silexion Therapeutics to helps clarify how Dec 31 2025's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SLXN/balance-sheets
https://api.csimarket.com/api/v1/companies/SLXN/fundamentals
https://api.csimarket.com/api/v1/companies/SLXN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024)
Assets
Cash & cash equivalent5.99
Restricted Cash and Cash Equivalents, Current0.03
Cash & Short-term Investments5.00
Other Current Assets0.05
Prepaid Expense, Current AS0.57
Total Current Assets6.64
Equipment/Property/Plant Net0.03
Deposits Assets, Noncurrent AS0.08
Other Assets, Noncurrent0.00
Restricted Cash Noncurrent0.06
Operating Lease Right Of Use Asset0.41
Total Assets7.22
Liabilities
Accounts Payable0.79
Employee-related Liabilities, Current AC0.88
Other Liabilities, Current1.09
Total Current Liabilities2.76
Total Long-term Debt0.00
Operating Lease Liability Current0.18
Private Warrant To Purchase Ordinary Shares-
Underwriters Promissory Notes Current Liabilities-
Operating Lease Liability Noncurrent0.29
Promissory Notes To Related Parties1.57
Total Liabilities4.61
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock57.73
Retained Earnings / Accumulated Deficit-55.17
Other Equity0.00
Common Stockholder's Equity2.60
Total Stockholder's Equity2.60
Liabilities & Stockholder's Equity7.22
4 historic quarters locked

Sign in to unlock the full Silexion Therapeutics balance sheet history.

Sign In Create Free Account

About Silexion Therapeutics Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 17, 2026
  • Source: zk2634529.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001178913-26-000953

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI